Oxytocin and the Brain: Social Behavior Beyond the Love Hormone Myth
Author: Ukrainian Psychological Hub · Published: October 12, 2026 · Editorial Policy
Oxytocin is a nine-amino-acid neuropeptide produced primarily by neurons in the hypothalamus. It helps regulate childbirth and milk ejection, and it contributes to neural processes involved in caregiving, social information, reproductive behavior, and context-sensitive responses to other people. Its effects depend on the receptor-bearing cells involved, the surrounding circuit, the organism's physiological state, and the social situation. An accurate answer to “what does oxytocin do in the brain?” therefore explains conditional neural signaling rather than claiming that one chemical creates love. Yao and Kendrick (2025)
The popular label “love hormone” arose from important experimental findings on bonding and trust. It is now scientifically incomplete. Some studies report changes in trust or social attention, others find no effect, and some identify increased in-group preferences. Systematic reviews raise substantial concerns about replication and the translation of laboratory effects into practical outcomes. Bartz et al. (2011) Mierop et al. (2020)
What is oxytocin?
Oxytocin is a peptide hormone and a brain neuromodulator. In the circulation, it acts on peripheral tissues, especially the uterus during labor and the mammary system during breastfeeding. Within the brain, it can modulate the activity of particular neurons and networks. The same molecule participates in both modes of physiology, yet the location, timing, and route of release determine which effects are possible. A concentration measured in blood does not simply equal oxytocin's activity in the living brain. Tabak et al. (2023)
The oxytocin receptor, commonly abbreviated OXTR, is a G-protein-coupled receptor. Activation influences intracellular signaling and can change the responsiveness of the receiving cell. The outcome depends on receptor expression, neural cell type, local excitation and inhibition, and other chemical messages. Oxytocin is evolutionarily related to vasopressin, another peptide involved in endocrine regulation and selected neural functions. Neither molecule corresponds to one psychological trait. Yao and Kendrick (2025)
Is oxytocin a hormone or a neurotransmitter?
Oxytocin can be described as a hormone because it travels through the blood after neuroendocrine release. It is also a neuropeptide used for signaling within nervous tissue, where its effects are often neuromodulatory. These classifications address the molecule's biological role and route of action, rather than offering mutually exclusive identities. For the general categories and mechanisms of chemical signaling, read Neurotransmitters: How Chemical Messages Affect the Brain.
Where is oxytocin produced and released?
Its principal source is the paraventricular and supraoptic nuclei of the hypothalamus. Many magnocellular neurons project to the posterior pituitary and release oxytocin into the bloodstream. Other neural processes, including projections and local release within the central nervous system, make it possible for the peptide to influence brain circuits. Peptide release does not have to match the rapid, point-to-point behavior of a classical fast excitatory synapse. Yao and Kendrick (2025)
The pattern of neuronal firing matters. During lactation, synchronized bursts of oxytocin neuron activity participate in pulsatile milk-ejection physiology. Studies examine how central release following bursts may influence multiple receptor-bearing targets. Such studies offer mechanistic insights but do not themselves demonstrate a specific emotional outcome in human parents. Maier et al. (2026)
Key brain structures and neural networks
Oxytocin receptors are distributed unevenly, and their expression varies among species, developmental periods, and cell populations. The hypothalamus organizes endocrine and autonomic responses to internal conditions. Amygdala networks contribute to processing salient social cues and learning about uncertain or threatening information; the amygdala cannot be reduced to a fear switch. The prefrontal cortex and cingulate regions participate in valuation, regulation, and context-sensitive choice. The insula contributes to processing bodily signals and attention to important events. Striatal and midbrain circuits contribute to motivated action. Oxytocin can modify the operation of selected elements within these distributed systems. Yao and Kendrick (2025)
A receptor map can reveal a possible biological target but does not show which psychological function that region owns. Likewise, a functional-imaging result cannot identify love or trust purely from the activation of a named brain area. Social responses emerge through coordinated activity, sensory information, learning, physiological state, and a situation's meaning. For broader anatomy and circuitry, see How the Brain Produces Behavior: Neurons, Circuits, and Networks.
How does oxytocin act on neurons?
Oxytocin signaling can alter excitability, inhibition, sensory processing, and the conditions under which synaptic plasticity occurs. Different receptor-bearing cells respond in different ways. A change that improves responsiveness to a caregiver's cue in one circuit can have a different behavioral significance in a setting involving a stranger or an ambiguous threat. The most informative question is which cells and task were studied, how the intervention was delivered, and what changed. Froemke and Young (2021)
Neural plasticity refers to changes in neural properties and organization that can arise through experience and biological conditions. Animal studies offer evidence that oxytocin can modify how social or sensory cues influence circuit activity and learning. Many causal experiments use genetic labeling, electrophysiology, or interventions targeting identified cells in mice, voles, or other species. Their precision does not remove the need for human evidence, because receptor patterns, environments, and learned behaviors differ. Froemke and Young (2021)
Oxytocin, dopamine, serotonin, and vasopressin
Oxytocin is part of a network of interacting systems. Dopamine contributes to movement, action selection, reinforcement learning, and motivation; calling it the pleasure chemical obscures important functions. Serotonin has multiple receptor-dependent effects and cannot be summarized as a happiness chemical. Vasopressin is closely related to oxytocin and has endocrine and neural functions. The social consequences of oxytocin signaling can involve interactions with these systems and with learned expectations. Background articles include Dopamine: Reward Prediction, Learning, Motivation, and Movement and Serotonin: Brain Functions, Mood Claims, and Scientific Evidence.
The history of the love-hormone narrative
Studies of maternal physiology and socially bonding mammals helped establish the idea that oxytocin might influence attachment. An influential 2005 placebo-controlled study reported increased financial investment in a trust game following intranasal oxytocin. This was an experimentally defined result about trust-related behavior in that game, not an investigation proving that a molecule generates love or long-term commitment. Kosfeld et al. (2005)
Human romantic attachment involves perception, attraction, interpersonal history, reciprocal behavior, emotion, and memory across time. The meaning of trust changes from one situation to another. A pharmacological influence on one laboratory decision cannot explain all of these features. By 2011, a major review emphasized that context and individual characteristics helped determine oxytocin effects. This was a productive correction to popular stories that predicted universal kindness or affection. Bartz et al. (2011)
Oxytocin, attachment, and pair bonding
Researchers have investigated oxytocin signaling in mammalian social recognition, mating relationships, parenting, and motivated behavior. Pharmacological experiments in certain animal models support a causal role under specific conditions. But necessity is a stronger claim than involvement. A biological factor can influence a process without being required for every instance of it, and different experimental manipulations can produce apparently conflicting results. Froemke and Young (2021)
A 2023 study generated prairie voles lacking functional oxytocin receptors using CRISPR gene editing. The receptor-null animals still showed partner preference and parental care in the conditions tested. These findings challenge the assumption that normal oxytocin receptor signaling is absolutely necessary for pair bonding. The study also raises questions about developmental compensation, other peptide pathways, and differences between lifetime receptor absence and acute drug intervention. Animal findings must not be directly converted into rules about human romance. Berendzen et al. (2023)
Human relationships cannot be meaningfully assessed through one hormone value. Attachment may include trust, continuity of care, shared history, responsiveness, safety, and social meaning. Its biological components are important subjects of research, while its quality must be understood across psychological and relational processes.
What happens during childbirth and breastfeeding?
Oxytocin's role in uterine contractions and milk ejection is established physiology. During nursing, sensory stimulation and hypothalamic signaling coordinate peripheral release. Researchers are also studying how maternal physiology, oxytocin bursts, neural circuits, and stress-related responses may interact during adaptation to infant care. Those neural hypotheses require careful separation from the physiological reflexes that are already demonstrated. Maier et al. (2026)
Breastfeeding difficulties or choosing formula cannot be interpreted as a lack of love. Parent–infant attachment is shaped by experiences, communication, responsive caregiving, health, and support. A systematic review of studies on oxytocin and postpartum depression reported considerable methodological heterogeneity and evidence insufficient for reliable conclusions about an association. Postpartum emotional symptoms warrant ordinary clinical evaluation, rather than assignment to an unmeasured neurochemical cause. Thul et al. (2020)
Does oxytocin increase trust and empathy?
These experimental questions belong within a wider discipline examining how people perceive, interact with, and respond to one another. For its key methods and inferential limits, read Social Neuroscience: How Researchers Study the Social Brain.
Some controlled experiments report effects on trust games, recognition of emotional expressions, empathy tasks, and social decision-making. Their operationalized outcomes differ, and findings do not always reproduce. It matters whether participants are familiar with one another, whether a task involves financial risk, how empathy is defined, whether a dose was delivered correctly, and what the comparison actually measures. A result in an incentivized game is not automatically a change in everyday interpersonal trust.
A 2025 systematic review assessed 75 studies examining exogenous oxytocin effects on emotion recognition, empathy, and trust. Most used 24 international units. The evidence for a dose-response curve, including claims of an optimal moderate dose, was inconsistent. Many conclusions about dose came from comparisons across studies rather than a direct randomized comparison of different doses in the same experiment. Moderation by the participant and context further limits the idea of a universal enhancement dose. Barton et al. (2025)
Replication raises additional concerns. A systematic review of interactive intranasal-oxytocin findings found major heterogeneity, limited independent replication, and frequent unsuccessful replications when attempted. Many studies were statistically underpowered to distinguish real person-by-treatment interactions from chance patterns. Such findings justify more rigorous research and lower confidence in strong everyday behavioral claims. Mierop et al. (2020)
Can oxytocin promote social favoritism or defensive behavior?
Some laboratory findings challenge an unconditional prosocial interpretation. A placebo-controlled series involving Dutch men found increases in particular measures of in-group favoritism and sometimes out-group derogation after oxytocin administration. The results concern tested participants and game-like tasks, not a general rule that oxytocin creates aggression or prejudice. They demonstrate the importance of social group context. De Dreu et al. (2011)
A plausible explanation is that oxytocin modifies the salience or behavioral relevance of social cues rather than uniformly producing warmth. Under one set of conditions, this may help respond to affiliative cues. Under another, attention to uncertainty or group boundaries might increase. Such models need specific predictions and independent replication before they can be treated as general principles. Bartz et al. (2011)
Why personal and situational factors matter
Human social behavior depends on history, expectations, environment, physiological state, and the interaction partner. Oxytocin manipulation enters that system rather than acting on an isolated psychological variable. If a signal has different meanings in different situations, changing sensitivity to it may produce different outcomes. But inconsistent results can also emerge from statistical noise, publication practices, poor standardization, and small samples. The scientific task is to distinguish genuine moderation from unreproduced exploratory patterns. Mierop et al. (2020)
A 2024 review found that many earlier intranasal oxytocin studies used male-only samples. Neuroimaging findings suggested some sex-related differences, particularly in responses involving amygdala regions, while behavioral outcomes remained variable and context-dependent. These group findings provide testable hypotheses; they are not a way to predict how a particular man or woman will respond to a hormone. Procyshyn et al. (2024)
What can oxytocin measurements actually tell us?
A hormone assay detects an estimated concentration in a particular specimen at a particular time. Plasma, saliva, urine, and cerebrospinal fluid differ in biological meaning and methodological challenges. Samples are affected by collection conditions, storage, extraction, assay technique, time of day, and other factors. A number presented without those details cannot support a reliable psychological interpretation. Tabak et al. (2023)
Peripheral oxytocin: blood, saliva, and urine
A 2019 systematic review and meta-analysis examined 229 studies with 12,741 participants. It found that reported concentrations varied substantially by specimen and assay procedure; unextracted blood estimates were particularly different from extracted estimates. Demographic and timing factors also contributed to variation. This directly undermines simplistic comparisons among “oxytocin levels” reported by unrelated studies. Engel et al. (2019)
A preregistered meta-analysis of central–peripheral oxytocin correlations found a pooled overall association, but virtually no reliable association under basal conditions: r approximately 0.08. Stronger correlations occurred after experimental stress or intranasal dosing. Thus, resting plasma or saliva concentrations do not provide a dependable index of central oxytocin signaling, and neither measurement can diagnose the quality of someone's social connection. Valstad et al. (2017)
Cerebrospinal fluid and central signaling
A cerebrospinal-fluid sample provides information about a sampled central compartment. It does not identify local transient release at a specific receptor-bearing synapse, nor does it map which network responded. Central and peripheral endocrine dynamics may be coordinated in some experimental conditions and relatively independent in others. Reviews recommend validated, transparent measurement protocols and stronger integration with biologically relevant time scales. Tabak et al. (2023)
Intranasal administration
A randomized placebo-controlled experiment can estimate whether a defined intervention affects a specified outcome in the studied participants. It does not, by itself, establish where the administered peptide acted or how naturally released oxytocin functions. Investigators debate the relative involvement of access to central pathways, indirect peripheral effects, dose, delivery technique, and timing. Claims that a nasal spray delivers a known dose to a particular emotional center in the brain exceed the evidence. Yao and Kendrick (2025)
The difference between an acute dose and the endogenous signaling system is essential. An experimental effect on recognizing faces, for example, does not establish that changes in spontaneous release cause the same effect, nor does it demonstrate a lasting change in social functioning. Well-powered trials and repeated independent studies remain necessary.
What do fMRI, EEG, and PET measure in oxytocin research?
Functional MRI commonly measures changes in the blood-oxygen-level-dependent (BOLD) signal, a hemodynamic proxy related to neural activity. It does not measure oxytocin molecules or subjective love. A change in an amygdala BOLD contrast after drug administration reveals an effect associated with a particular task and imaging analysis, not a universal increase or decrease in fear or trust. Reverse inference from a multifunctional region to one mental state is scientifically unreliable.
EEG measures electrical potentials at the scalp arising largely from coordinated neural activity; it provides excellent temporal information while having localization limitations. PET measures the distribution of an appropriately validated radiotracer in connection with metabolism, receptor binding, or another target. A generic PET scan is not an oxytocin detector. Measurements across these methods are useful for constrained experimental hypotheses but cannot establish a clinical diagnosis or a person's private emotional experience. See Brain Imaging Methods: What MRI, fMRI, PET, and EEG Measure.
Neuroimaging studies reporting sex-related differences in responses to oxytocin illustrate how participant sampling and tasks influence observed effects. Imaging can help study neural response patterns; it remains several inferential steps away from molecular mechanism and experienced emotion. Animal experiments that manipulate identified receptors or cells provide different causal evidence and carry translation limits. Procyshyn et al. (2024)
Oxytocin, stress, and emotion regulation
Oxytocin is investigated in stress-related physiological and social responses. A supportive environment, perceived safety, prior learning, autonomic activity, and neuroendocrine state can all change the outcome. Some experiments report altered response to stress-related information, but this does not establish that oxytocin invariably lowers stress or treats an anxiety disorder. Biological responses, self-reported feelings, and changes in clinical symptoms must be measured separately. Yao and Kendrick (2025)
A 2025 systematic review of randomized fMRI studies in anxiety and stress-related disorders found heterogeneous evidence regarding neural responses and insufficient basis for broad clinical efficacy claims. A drug might alter a task-specific signal without improving daily functioning. The broader mechanisms of emotion and regulation belong to Neural Basis of Emotion: Brain Networks, Learning, and Regulation. Moshfeghinia et al. (2025)
Is oxytocin an established mental-health treatment?
Intranasal oxytocin has been studied in autism, schizophrenia, and other mental-health conditions. A mechanistic hypothesis or an improvement in a narrow behavioral task is distinct from a clinically meaningful treatment effect. A clinical trial must assess predefined outcomes, adverse effects, dose, duration, and comparison with appropriate care.
A large randomized 24-week trial enrolled 290 children and adolescents with autism spectrum disorder. Intranasal oxytocin did not significantly outperform placebo on the main measure of social withdrawal or key secondary outcomes. The findings weigh heavily against the idea that oxytocin is already an established general autism treatment, while leaving more narrowly defined future research questions open. Sikich et al. (2021)
A 2026 meta-analysis synthesized 42 double-blind randomized trials involving 1,922 participants across mental disorders. The pooled effect was small and statistically nonsignificant (Hedges' g 0.17; 95% confidence interval −0.05 to 0.38). After excluding two outlying studies, the estimate was 0.05 (95% CI −0.03 to 0.12). A limited signal for negative symptoms in schizophrenia was reported, requiring targeted confirmation; it does not establish a broad indication. Bonnieux et al. (2026)
Claims about biomarkers must follow the same evidence standards. Neither a blood concentration nor a nonspecific imaging contrast is a validated individual diagnostic test for attachment difficulties, autism, loneliness, depression, or social anxiety. Diagnostic evaluation depends on appropriate clinical criteria, symptoms, functioning, context, and professional assessment. Unsupervised oxytocin sprays marketed to create love, confidence, or social connection are not supported by the current treatment evidence.
Leading theoretical models
Social-salience accounts propose that oxytocin changes processing of socially meaningful stimuli, with direction dependent on what the stimuli signify. Context-and-person models describe interactions among biological state, individual characteristics, and situation. Integrative accounts connect reproductive biology and social processes to broader survival and security needs. These are partially overlapping scientific explanations rather than a settled single theory. Bartz et al. (2011) Yao and Kendrick (2025)
A useful model must predict which measurement changes, in which direction, under which circumstances, and when no effect is expected. It must be distinguishable from alternative explanations by prospective experiments, not merely fit conflicting results after they appear. Replication, transparent analysis, adequate power, and direct tests of mechanisms are essential for progress.
Evidence status: what is established and what remains uncertain?
Established evidence concerns the hormone's hypothalamic origin, its roles in parturition and milk ejection, OXTR-mediated signaling, and measurable effects in selected animal neural circuits. These claims are grounded in decades of endocrine, receptor, pharmacological, and mechanistic evidence. Froemke and Young (2021)
Conditional or preliminary evidence includes the specific direction and magnitude of many human effects on trust, empathy, social evaluation, neural imaging, stress responses, and subgroup treatment outcomes. Results can vary by task, population, dose, and study design. Replication difficulties affect confidence in some published claims. Barton et al. (2025) Mierop et al. (2020)
Claims that oxytocin always produces love, is essential for every pair bond, can be inferred from routine blood tests, or already treats diverse mental disorders are not supported as universal scientific conclusions. Receptor-null prairie vole experiments, assay studies, and large randomized clinical evidence demonstrate the boundaries of those statements. Berendzen et al. (2023) Bonnieux et al. (2026)
Common myths about oxytocin
Myth: Oxytocin alone creates romantic love
Oxytocin contributes to selected biological and behavioral processes. Love involves learned significance, interpersonal experience, reciprocal actions, memory, and cultural meaning over time. A single neurochemical variable is insufficient to explain it.
Myth: More oxytocin always increases trust and empathy
Human intervention findings are mixed, context-sensitive, and subject to replication limitations. Reviews do not establish a consistent ideal dosage for enhancing everyday empathy or trust. Barton et al. (2025)
Myth: A low hormone level proves poor attachment
Peripheral values are sensitive to assay, specimen, and timing. Resting peripheral values do not reliably indicate central signaling and cannot classify a person's attachment quality. Engel et al. (2019) Valstad et al. (2017)
Myth: Oxytocin is a clinically proven treatment for social difficulties
A 2026 synthesis of randomized psychiatric trials found no statistically significant overall benefit. Specific potential clinical applications remain hypotheses for targeted controlled trials. Bonnieux et al. (2026)
Myth: Imaging activation proves how someone feels
The amygdala, prefrontal cortex, and other regions participate in many neural computations. BOLD activity is a hemodynamic measurement. Neither can independently decode affection, truthfulness, or trust.
Practical implications
The most helpful way to read an oxytocin claim is to identify its evidence type. Was peptide concentration sampled from blood or saliva? Was a drug administered? Was a receptor experimentally manipulated in an animal? Was a brain response recorded? Was a patient-relevant clinical benefit demonstrated? Each approach supplies different information and supports a different level of causal inference.
For relationships, the quality of interaction, communication, care, and reliability remain observable, meaningful domains. For clinical decisions, established diagnostic and treatment practices provide the appropriate framework. For researchers, priorities include validated assays, receptor- and circuit-specific experiments, well-powered human studies, preregistered comparisons, and responsible interpretation of null findings.
Frequently asked questions
What does oxytocin do in the brain?
It modulates signaling in selected neural circuits involved in physiological regulation, social cues, caregiving, learning, and context-dependent behavior. Its effects vary by receptor distribution, organism, experience, and experimental conditions. Yao and Kendrick (2025)
Is oxytocin a neurotransmitter or a hormone?
It is a neuropeptide with both endocrine functions in blood and neuromodulatory functions in the nervous system. The two forms of release are related but physiologically distinct.
Does oxytocin make people fall in love?
There is no established evidence that dosing oxytocin creates lasting romantic attachment. Certain experiments report changes in narrowly measured social responses, which depend on context and do not establish a general formula for relationships.
Does hugging release oxytocin?
Social contact and touch are studied as candidate influences on endogenous oxytocin signaling, but assays and study designs vary. A hug cannot be translated into a reliable numerical prediction of oxytocin release in the brain.
Can oxytocin increase aggression or bias?
Some experiments find greater in-group preference or particular defensive social responses. Their meaning depends on task and participant population; the evidence does not support a universal aggression rule. De Dreu et al. (2011)
Does oxytocin differ from dopamine?
Oxytocin is a neuropeptide with central and endocrine signaling functions. Dopamine is a catecholamine neurotransmitter important for movement, learning, and motivation. They can interact within some neural processes but have different receptor systems and physiological roles.
Can a blood test show my brain's oxytocin level?
At baseline, peripheral concentrations do not reliably track central concentrations. Assay and specimen conditions introduce substantial additional variability. Valstad et al. (2017)
Can low oxytocin cause autism or anxiety?
Research has not validated such a general individual causal or diagnostic rule. Clinical conditions are assessed through established criteria, and the major autism intervention trial did not show a benefit on its primary endpoint. Sikich et al. (2021)
Is oxytocin spray an effective mental-health treatment?
Across 42 randomized psychiatric trials in a 2026 meta-analysis, no statistically significant overall benefit was detected. Potential narrowly defined applications remain under investigation. Bonnieux et al. (2026)
Does breastfeeding determine the strength of parental attachment?
Oxytocin has an established physiological role in milk ejection, but human attachment is shaped by multiple biological, experiential, and relational factors. Breastfeeding status is not a measure of parental love or bonding quality. Thul et al. (2020)
Conclusion
Oxytocin is an important neuroendocrine and neuromodulatory peptide that helps link biological state, receptor signaling, and selected forms of social behavior. Its most reliable lessons arise from mechanistic research, rigorous experiments, measurement science, and synthesized clinical findings. The love-hormone label conveys one familiar association but cannot represent the complexity of oxytocin signaling or the psychological processes of human relationships. Scientific progress depends on explaining precise mechanisms, contextual effects, and limits of inference.
Related Articles
References
Barton, S., Pruin, A., Schulze, J., et al. (2025). Dose-response effects of exogenous oxytocin on social cognition: A systematic review. Neuroscience & Biobehavioral Reviews, 178, 106350. https://doi.org/10.1016/j.neubiorev.2025.106350
Bartz, J. A., Zaki, J., Bolger, N., & Ochsner, K. N. (2011). Social effects of oxytocin in humans: Context and person matter. Trends in Cognitive Sciences, 15(7), 301–309. https://doi.org/10.1016/j.tics.2011.05.002
Berendzen, K. M., Sharma, R., Mandujano, M. A., et al. (2023). Oxytocin receptor is not required for social attachment in prairie voles. Neuron, 111(6), 787–796.e4. https://doi.org/10.1016/j.neuron.2022.12.011
Bonnieux, J., Gumuchian, S. T., Harboun, A., et al. (2026). Does intranasal oxytocin reduce symptoms of mental disorders? A meta-analysis of clinical trials. Neuroscience & Biobehavioral Reviews, 187, 106749. https://doi.org/10.1016/j.neubiorev.2026.106749
De Dreu, C. K. W., Greer, L. L., Van Kleef, G. A., Shalvi, S., & Handgraaf, M. J. J. (2011). Oxytocin promotes human ethnocentrism. Proceedings of the National Academy of Sciences, 108(4), 1262–1266. https://doi.org/10.1073/pnas.1015316108
Engel, S., Laufer, S., Miller, R., et al. (2019). Demographic, sampling- and assay-related confounders of endogenous oxytocin concentrations: A systematic review and meta-analysis. Frontiers in Neuroendocrinology, 54, 100775. https://doi.org/10.1016/j.yfrne.2019.100775
Froemke, R. C., & Young, L. J. (2021). Oxytocin, neural plasticity, and social behavior. Annual Review of Neuroscience, 44, 359–381. https://doi.org/10.1146/annurev-neuro-102320-102847
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005). Oxytocin increases trust in humans. Nature, 435, 673–676. https://doi.org/10.1038/nature03701
Maier, E., Lan, W., Schimmer, S., Ishiyama, S., & Grinevich, V. (2026). Beyond lactation: Central oxytocin in maternal mental health and disease. Neuroscience & Biobehavioral Reviews, 186, 106697. https://doi.org/10.1016/j.neubiorev.2026.106697
Mierop, A., Mikolajczak, M., Stahl, C., et al. (2020). How can intranasal oxytocin research be trusted? A systematic review of the interactive effects of intranasal oxytocin on psychosocial outcomes. Perspectives on Psychological Science, 15(5), 1228–1242. https://doi.org/10.1177/1745691620921525
Moshfeghinia, R., Sanaei, E., Kavari, K., et al. (2025). Exploring the efficacy of intranasal oxytocin for anxiety and stress-related disorders through fMRI: A systematic review. BMC Pharmacology and Toxicology, 26, 162. https://doi.org/10.1186/s40360-025-00996-y
Procyshyn, T. L., Dupertuys, J., & Bartz, J. A. (2024). Neuroimaging and behavioral evidence of sex-specific effects of oxytocin on human sociality. Trends in Cognitive Sciences, 28(10), 948–961. https://doi.org/10.1016/j.tics.2024.06.010
Sikich, L., et al. (2021). Intranasal oxytocin in children and adolescents with autism spectrum disorder. New England Journal of Medicine, 385, 1462–1473. https://doi.org/10.1056/NEJMoa2103583
Tabak, B. A., Leng, G., Szeto, A., et al. (2023). Advances in human oxytocin measurement: Challenges and proposed solutions. Molecular Psychiatry, 28, 127–140. https://doi.org/10.1038/s41380-022-01719-z
Thul, T. A., Corwin, E. J., Carlson, N. S., Brennan, P. A., & Young, L. J. (2020). Oxytocin and postpartum depression: A systematic review. Psychoneuroendocrinology, 120, 104793. https://doi.org/10.1016/j.psyneuen.2020.104793
Valstad, M., Alvares, G. A., Egknud, M., et al. (2017). The correlation between central and peripheral oxytocin concentrations: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 78, 117–124. https://doi.org/10.1016/j.neubiorev.2017.04.017
Yao, S., & Kendrick, K. M. (2025). How does oxytocin modulate human behavior? Molecular Psychiatry, 30, 1639–1651. https://doi.org/10.1038/s41380-025-02898-1